Virica Biotech - Viral Sensitizers (VSE)
We pioneered a new product category of Viral Sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. Customized VSE formulations optimize research processes and enhance production. Virica was founded in 2018 based on a decade of research in the laboratory of Dr. Recent influenza outbreaks and the COVID-19 pandemic highlight the need for scalability in the production of vaccines. Virica has the products and experience to combat these challenges. Here is a snapshot of organizations with whom we share knowledge by attending meetings or giving presentations. Virica is a member of BIOTECanada, an association building a climate for biotechnology firms to succeed in today’s hyper-competitive economy. Virica is a member of Alliance of Regenerative Medicine.
This company is:
Verified
Virica Biotech - Virtual Tour of Virica’s Process Innovation Facility In the press
We now have officially launched our Process Innovation Facility! Take a look at where we enhance the manufacturing of viral medicine.
Verified
Virica Biotech - Virtual Grand Opening of Virica’s Process Innovation Facility In the press
Watch the grand opening of Virica’s Process Innovation Facility.
Verified
Virica Biotech - Technology for Drug Developers and Manufacturers
Use Viral Sensitizers (VSE) to manufacture complex and effective viral medicines when scale needs to be achieved; VSEs are small molecules that improve viral yield and effectiveness.
View all products
Keywords
Industries
Where is Virica Biotech located?
The company Virica Biotech is located in Ottawa, Ontario, Canada. It's worth noting that the company may has more corporate locations
How many employees does Virica Biotech approximately have?
As of the latest available information Virica Biotech has around 11-50 employees worldwide.
When was Virica Biotech founded?
Virica Biotech was founded in 2018
In which industries does Virica Biotech mainly work?
The company Virica Biotech has it's main focus in the industries of Biotechnology, Science and Engineering, Health Care
Vir Biotechnology
United States
101-250 Employees
2016
Virovet
Belgium
11-50 Employees
2015
Vira Therapeutics
Austria
11-50 Employees
2015
RetroVirox
United States
1-10 Employees
2008
ImmVirX
Australia
11-50 Employees
2019
Virogin Biotech
Canada
11-50 Employees
2015
Benevira
United States
1-10 Employees
2021
Virocell Biologics
United Kingdom
Topics which have been searched by others and may be interesting for you: